Skip to main navigation Skip to search Skip to main content

Combination therapy for dry AMD: targeting systemic and local inflammation synergistically with oral metformin and subretinal IRAK3 gene delivery

Project Details

Description

Macular Society
StatusFinished
Effective start/end date6/01/25 → 5/01/26

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.